Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Reliant Technologies Inc.

Oct 2007
Mountain View, Calif.-based Reliant Technologies Inc., a developer of clinical techniques for repairing and rejuvenating aging and environmentally damaged skin, has received FDA clearance for ablation, coagulation and skin resurfacing using its Fraxel re:pair laser system, based on ongoing results from two rounds of clinical trials. The system performs fractional deep dermal ablation treatment, which leads to tissue contraction and tightening and to collagen remodeling. The laser will remove aged and damaged skin without prolonged downtime or adverse reactions associated with surgical procedures and conventional ablative resurfacing lasers, according to the company. The instrument combines conventional CO2 resurfacing with fractional photothermolysis to treat only a portion of the skin’s surface, leaving the surrounding areas intact so they can heal.

BiophotonicsNews & FeaturesReliant Technologies Inc.

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.